Porton Advanced, a leading cell and gene therapy CDMO, recently announced its client Salvectors has received Investigational New Drug (IND) clearance for their proprietary and innovative oncolytic ...

As clinical development becomes increasingly complex and costly, biotech and pharmaceutical companies are rethinking how they partner with contract research organizations (CROs) to harmonize speed, ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

Children's Nebraska CIO Ryan Cameron is developing a program for clinicians to learn vibe coding and create apps.

Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable ...

NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other ...

One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin ...

In this webinar, Gonçalo Regalo discusses how raw materials, media composition, and process design influence scalable cell ...

A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...

SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...

PET tracers are used in PET scans. PET scans make it possible to visualize and measure biological processes in the body. By injecting a small amount of radioactive tracer into the body, doctors can, ...

The data published in NEJM reflect outcomes in the PDAC cohort from the RMC-6236-001 trial (NCT05379985), an open-label, multicenter Phase 1/2 trial evaluating daraxonrasib monotherapy in patients ...